{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:20:58Z","timestamp":1791897658792,"version":"4.3.4"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"14","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Visceral adipose tissue (VAT) has been related to coronary artery disease (CAD), but its association with recurrent major adverse cardiovascular events (MACE) in premature CAD (pCAD) has not been fully explored. Thus, we aimed to investigate the impact of VAT on recurrent MACE in patients with pCAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This was a retrospective sub-analysis of 853 patients with pCAD from the GEA cohort study. Visceral adipose tissue was measured by computed tomography at baseline. The primary outcome was the recurrence of MACE over 5 years of follow-up. Likewise, the association of VAT with non-fatal and fatal MACE was analysed as a secondary outcome. Cox regression models were fitted and adjusted by confounders obtained at baseline to estimate adjusted hazard ratios (aHRs). The median age of the patients was 53 years, and 80% were male, with a median follow-up of 4.9 years. Overall, 10% of the patients had recurrent MACE (6.5% non-fatal and 3.6% fatal) with an incidence rate of 18.5 [95% confidence interval (CI): 18.0\u201319.0] events per 1000 person-years. Visceral adipose tissue was positively associated with MACE. Those in the upper tertile (VAT \u2265 194\u2005cm\u00b2) had the highest risk for total (aHR: 2.71; 95% CI: 1.37\u20135.35; P = 0.004) and non-fatal (aHR: 3.58; 95% CI: 1.49\u20138.61; P = 0.004) MACE. Fatal MACE was not statistically associated (aHR: 2.13; 95% CI: 0.72\u20136.35; P = 0.174).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among patients with pCAD, VAT increased the risk of recurrent MACE despite adequate pharmacological treatment. These results suggest that VAT could be considered an emergent risk factor and a promising target for residual cardiovascular risk reduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lay summary<\/jats:title>\n                    <jats:p>This study explores how visceral adipose tissue (VAT), a type of body fat located around internal organs, elevates the risk of recurrent cardiovascular events in patients with premature coronary artery disease (pCAD), even with optimal medical treatment.<\/jats:p>\n                    <jats:p>Key finding 1: Patients with elevated VAT levels faced a significantly higher risk of recurrent major cardiovascular events.<\/jats:p>\n                    <jats:p>Key finding 2: These results indicate that reducing VAT through lifestyle modifications or targeted interventions could decrease cardiovascular risks in patients with pCAD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwaf074","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T23:20:29Z","timestamp":1739488829000},"page":"2582-2592","source":"Crossref","is-referenced-by-count":6,"title":["Visceral adipose tissue is associated with recurrent cardiovascular events in premature coronary artery disease: sub-analysis of the GEA study cohort"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1934-5095","authenticated-orcid":false,"given":"Aida X","family":"Medina-Urrutia","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez , Juan Badiano 1, Secci\u00f3n XVI, Del. Tlalpan, Mexico City C.P. 14080 ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6879-1078","authenticated-orcid":false,"given":"Neftali Eduardo","family":"Antonio-Villa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2719-1105","authenticated-orcid":false,"given":"Froylan D","family":"Mart\u00ednez-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Manuel Gea Gonz\u00e1lez Hospital , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-3488","authenticated-orcid":false,"given":"Rosalinda","family":"Posadas-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3093-937X","authenticated-orcid":false,"given":"Omar Yaxmehen","family":"Bello-Chavolla","sequence":"additional","affiliation":[{"name":"Research Division, Instituto Nacional de Geriatr\u00eda , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3013-9436","authenticated-orcid":false,"given":"Mar\u00eda del Roc\u00edo","family":"Mart\u00ednez-Alvarado","sequence":"additional","affiliation":[{"name":"Department of Outpatients Care, Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7748-4678","authenticated-orcid":false,"given":"Esteban","family":"Jorge-Galarza","sequence":"additional","affiliation":[{"name":"Department of Outpatients Care, Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8864-2304","authenticated-orcid":false,"given":"Juan G","family":"Ju\u00e1rez-Rojas","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez , Juan Badiano 1, Secci\u00f3n XVI, Del. Tlalpan, Mexico City C.P. 14080 ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"2026101219573329200_zwaf074-B1","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990\u20132022","volume":"82","author":"Mensah","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026101219573329200_zwaf074-B2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/eurjpc\/zwae240","article-title":"Early-onset atherosclerotic cardiovascular disease","volume":"32","author":"Mousavi","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"2026101219573329200_zwaf074-B3","doi-asserted-by":"crossref","first-page":"e012178","DOI":"10.1161\/JAHA.119.012178","article-title":"Premature atherosclerotic cardiovascular disease: trends in incidence, risk factors, and sex-related differences, 2000 to 2016","volume":"8","author":"Vikulova","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026101219573329200_zwaf074-B4","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/eurjpc\/zwae171","article-title":"Rethinking weight loss treatments as cardiovascular medicine in obesity, a comprehensive review","volume":"31","author":"Tuccinardi","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026101219573329200_zwaf074-B5","doi-asserted-by":"crossref","first-page":"2042018820943374","DOI":"10.1177\/2042018820943374","article-title":"Metabolic control achievement in a population with premature coronary artery disease: results of the genetics of atherosclerotic disease study","volume":"11","author":"Medina-Urrutia","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2026101219573329200_zwaf074-B6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","article-title":"Body fat distribution and risk of cardiovascular disease: an update","volume":"126","author":"Despr\u00e9s","year":"2012","journal-title":"Circulation"},{"key":"2026101219573329200_zwaf074-B7","doi-asserted-by":"crossref","first-page":"17034","DOI":"10.1038\/nrdp.2017.34","article-title":"Obesity","volume":"3","author":"Gonz\u00e1lez-Muniesa","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2026101219573329200_zwaf074-B8","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/ATVBAHA.106.131755","article-title":"Adipose tissue and atherosclerosis: exploring the connection","volume":"27","author":"Fantuzzi","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026101219573329200_zwaf074-B9","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1161\/CIRCULATIONAHA.114.015000","article-title":"Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors","volume":"132","author":"Abraham","year":"2015","journal-title":"Circulation"},{"key":"2026101219573329200_zwaf074-B10","doi-asserted-by":"crossref","first-page":"e13088","DOI":"10.1111\/obr.13088","article-title":"Visceral obesity and incident cancer and cardiovascular disease: an integrative review of the epidemiological evidence","volume":"22","author":"Silveira","year":"2021","journal-title":"Obes Rev"},{"key":"2026101219573329200_zwaf074-B11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.gendis.2020.11.003","article-title":"Pathogenesis of premature coronary artery disease: focus on risk factors and genetic variants","volume":"9","author":"Wang","year":"2020","journal-title":"Genes Dis"},{"key":"2026101219573329200_zwaf074-B12","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1177\/2047487319871735","article-title":"The challenge of multiple cardiovascular risk factor control outside Western Europe: findings from the International ChoLesterol management Practice Study","volume":"27","author":"Blom","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2026101219573329200_zwaf074-B13","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.numecd.2022.06.008","article-title":"Effect of metabolic control on recurrent major adverse cardiovascular events and cardiovascular mortality in patients with premature coronary artery disease: results of the Genetics of Atherosclerotic Disease study","volume":"32","author":"Martinez-Sanchez","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2026101219573329200_zwaf074-B14","doi-asserted-by":"crossref","first-page":"e49285","DOI":"10.1371\/journal.pone.0049285","article-title":"The ABCA1 gene R230C variant is associated with decreased risk of premature coronary artery disease: the Genetics of Atherosclerotic Disease (GEA) study","volume":"7","author":"Villarreal-Molina","year":"2012","journal-title":"PLoS One"},{"key":"2026101219573329200_zwaf074-B15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review","volume":"21","author":"Bosco","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"2026101219573329200_zwaf074-B16","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/ajcn\/48.6.1351","article-title":"Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations","volume":"48","author":"Kvist","year":"1988","journal-title":"Am J Clin Nutr"},{"key":"2026101219573329200_zwaf074-B17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/jch.12387","article-title":"Standards for the uniform reporting of hypertension in adults using population survey data: recommendations from the World Hypertension League Expert Committee","volume":"16","author":"Gee","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026101219573329200_zwaf074-B18","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"2026101219573329200_zwaf074-B19","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"2026101219573329200_zwaf074-B20","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1210\/jc.2017-00047","article-title":"How to measure adipose tissue insulin sensitivity","volume":"102","author":"S\u00f8ndergaard","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026101219573329200_zwaf074-B21","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"2026101219573329200_zwaf074-B22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2016.06.041","article-title":"Impact of adipose tissue composition on cardiovascular risk assessment in patients with stable coronary artery disease","volume":"251","author":"Kunimura","year":"2016","journal-title":"Atherosclerosis"},{"key":"2026101219573329200_zwaf074-B23","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ije\/dyaa213","article-title":"Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations","volume":"50","author":"Tennant","year":"2021","journal-title":"Int J Epidemiol"},{"key":"2026101219573329200_zwaf074-B24","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.jacc.2010.11.058","article-title":"Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data","volume":"57","author":"Coutinho","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026101219573329200_zwaf074-B25","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jacc.2008.05.051","article-title":"A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease","volume":"52","author":"Sch\u00f6mig","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026101219573329200_zwaf074-B26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026101219573329200_zwaf074-B27","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1210\/jc.2010-1378","article-title":"Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study","volume":"95","author":"Liu","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2026101219573329200_zwaf074-B28","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/eurjpc\/zwad099","article-title":"Visceral adiposity index and the risk of heart failure, late-life cardiac structure, and function in ARIC study","volume":"30","author":"Xu","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"2026101219573329200_zwaf074-B29","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/j.jacc.2017.09.1111","article-title":"Abdominal obesity is associated with an increased risk of all-cause mortality in patients with HFpEF","volume":"70","author":"Tsujimoto","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026101219573329200_zwaf074-B30","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1097\/JCN.0000000000000139","article-title":"The association between central fat distribution and recurrent cardiovascular disease events in female survivors of nonfatal myocardial infarction","volume":"30","author":"Bruce","year":"2015","journal-title":"J Cardiovasc Nurs"},{"key":"2026101219573329200_zwaf074-B31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/eurjpc\/zwae279","article-title":"Obesity and cardiovascular disease: an ESC clinical consensus statement","volume":"32","author":"Koskinas","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"2026101219573329200_zwaf074-B32","doi-asserted-by":"crossref","first-page":"1187735","DOI":"10.3389\/fcvm.2023.1187735","article-title":"Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options","volume":"10","author":"Cesaro","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026101219573329200_zwaf074-B33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11883-022-00996-x","article-title":"Overweight, obesity, and CVD risk: a focus on visceral\/ectopic fat","volume":"24","author":"Chartrand","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"2026101219573329200_zwaf074-B34","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.3399\/bjgp19X702725","article-title":"Comorbidity in patients with cardiovascular disease in primary care: a cohort study with routine healthcare data","volume":"69","author":"Buddeke","year":"2019","journal-title":"Br J Gen Pract"},{"key":"2026101219573329200_zwaf074-B35","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jcmg.2012.11.021","article-title":"Visceral and subcutaneous fat quality and cardiometabolic risk","volume":"6","author":"Rosenquist","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026101219573329200_zwaf074-B36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12933-023-01807-6","article-title":"Visceral adipose tissue is an independent predictor and mediator of the progression of coronary calcification: a prospective sub-analysis of the GEA study","volume":"22","author":"Antonio-Villa","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"2026101219573329200_zwaf074-B37","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/heartjnl-2014-305490","article-title":"The separate and combined effects of adiposity and cardiometabolic dysfunction on the risk of recurrent cardiovascular events and mortality in patients with manifest vascular disease","volume":"100","author":"van der Leeuw","year":"2014","journal-title":"Heart"},{"key":"2026101219573329200_zwaf074-B38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/21623945.2021.1893452","article-title":"Dysfunctional adiposity index as a marker of adipose tissue morpho-functional abnormalities and metabolic disorders in apparently healthy subjects","volume":"10","author":"Reyes-Barrera","year":"2021","journal-title":"Adipocyte"},{"key":"2026101219573329200_zwaf074-B39","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.numecd.2024.03.021","article-title":"The dysfunctional adiposity index is a clinical surrogate of pericardial fat in adults without premature CVD: a sub-analysis of the GEA Mexican study control group","volume":"34","author":"Reyes-Barrera","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2026101219573329200_zwaf074-B40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.gheart.2013.11.005","article-title":"Coronary heart disease and risk factors in Latin America","volume":"8","author":"Lanas","year":"2013","journal-title":"Glob Heart"},{"key":"2026101219573329200_zwaf074-B41","doi-asserted-by":"crossref","first-page":"1411678","DOI":"10.3389\/fendo.2024.1411678","article-title":"Prediction of visceral adipose tissue magnitude using a new model based on simple clinical measurements","volume":"15","author":"Torun","year":"2024","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf074\/61905727\/zwaf074.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/14\/2582\/61905727\/zwaf074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/14\/2582\/61905727\/zwaf074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:57:45Z","timestamp":1791849465000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/33\/14\/2582\/8016452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":41,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,2,17]]},"published-print":{"date-parts":[[2026,10,13]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwaf074","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2025,2,17]]}}}